Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator that acts primarily on blood vessels to improve blood flow. It is a beta-adrenergic agonist.
## Primary Indications
* Adjunctive therapy in intermittent claudication.
* Adjunctive therapy in peripheral arterial disease.
* Adjunctive therapy in cerebrovascular insufficiency.
Note: The efficacy of isoxsuprine for these indications is not definitively established and is subject to ongoing debate and regulatory review in various regions.
## Adult Dosing
* **Intermittent Claudication, Peripheral Arterial Disease, Cerebrovascular Insufficiency:**
* 10 mg to 20 mg orally every 3 to 4 times daily.
* Maximum dose: Not explicitly defined, but typically not to exceed 80 mg daily.
## Pediatric Dosing
* There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in pediatric patients is generally not recommended.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose adjustments are established.
* **Renal Impairment:** Use with caution. No specific dose adjustments are established.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Patients with congenital heart disease.
* Patients with recent myocardial infarction.
* Tachyarrhythmias.
## Adverse Effects
* **Common:** Nausea, vomiting, gastric distress, dizziness, lightheadedness, weakness, flushing, nervousness, drowsiness.
* **Less Common:** Hypotension, rash, abdominal pain, blurred vision, hypotension, palpitations.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine can potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetic agents:** May increase the risk of cardiovascular adverse effects like tachycardia and arrhythmias.
## Monitoring
* Blood pressure.
* Heart rate.
* Symptoms of claudication or peripheral/cerebrovascular insufficiency.
* Signs of adverse effects.
## Clinical Pearls
* Isoxsuprine hydrochloride is generally considered an adjunctive therapy.
* Its effectiveness for its approved indications has been questioned, and it may not be available in all markets.
* Patients should be advised to avoid activities requiring mental alertness until they know how the drug affects them.
* Discontinue use if symptoms worsen or significant adverse effects occur.
***
*Please verify current prescribing information and consult with a qualified healthcare professional for specific patient management decisions.*